TY - JOUR
T1 - Disagreement between guidelines regarding the third step of asthma drug therapy for school-age children
AU - Miceli Sopo, Stefano
AU - Bersani, Giuseppe
AU - Del Vescovo, Ester
AU - Gelsomino, Mariannita
PY - 2020
Y1 - 2020
N2 - With the help of a routine clinical case, we highlighted the difference between two of the best asthma guidelines available at the time regarding therapeutic suggestions for the so-called “third step” for school-age asthmatic children. We have analyzed the scientific evidence that each of the two guidelines brings to support their position. Finally, we have motivatedly solved the clinical scenario. However, the question of disagreement between two guidelines remains unresolved. This can lead to unjustified differences in the management of schoolchildren with persistent asthma.
AB - With the help of a routine clinical case, we highlighted the difference between two of the best asthma guidelines available at the time regarding therapeutic suggestions for the so-called “third step” for school-age asthmatic children. We have analyzed the scientific evidence that each of the two guidelines brings to support their position. Finally, we have motivatedly solved the clinical scenario. However, the question of disagreement between two guidelines remains unresolved. This can lead to unjustified differences in the management of schoolchildren with persistent asthma.
KW - Asthma guidelines
KW - Inhaled corticosteroid
KW - Leukotriene receptor antagonist
KW - Long-acting β2 agonist
KW - School-age children
KW - Asthma guidelines
KW - Inhaled corticosteroid
KW - Leukotriene receptor antagonist
KW - Long-acting β2 agonist
KW - School-age children
UR - http://hdl.handle.net/10807/167062
U2 - 10.1016/j.aller.2019.12.004
DO - 10.1016/j.aller.2019.12.004
M3 - Article
SN - 0301-0546
VL - 48
SP - 789
EP - 791
JO - Allergologia et Immunopathologia
JF - Allergologia et Immunopathologia
ER -